Corporate Presentation March 2019 TSXV: ALEF OTC: ALEAF Aleafia - - PowerPoint PPT Presentation

corporate presentation
SMART_READER_LITE
LIVE PREVIEW

Corporate Presentation March 2019 TSXV: ALEF OTC: ALEAF Aleafia - - PowerPoint PPT Presentation

Corporate Presentation March 2019 TSXV: ALEF OTC: ALEAF Aleafia Health Inc Confidential & Proprietary Certain Statements herein relating to the Company constitute forward looking statements within the meaning of Certain


slide-1
SLIDE 1

Aleafia Health Inc Confidential & Proprietary

Corporate Presentation

March 2019

TSXV: ALEF – OTC: ALEAF

slide-2
SLIDE 2

Confidential & Proprietary

2

Certain Statements herein relating to the Company constitute “forward looking statements” within the meaning of

Certain statements herein relating to the Company constitute “forward looking statements”, within the meaning of applicable securities laws, including without limitation, statements regarding future estimates, business plans and/or

  • bjectives, sales programs, forecasts and projections, assumptions, expectations, and/or beliefs of future

performance, are “forward-looking statements”. Such “forward-looking statements involve unknown risks and uncertainties that could cause actual and future events to differ materially from those anticipated in such statements. Forwardlooking statements include, but are not limited to, statements with respect to commercial operations, including production and/or sales of marijuana, quantities of future marijuana production, anticipated revenues in connection with such sales, the overall projected size of the market, completion and/or expansion of production facilities, and other Information that is based on forecasts of future results, estimates of production not yet determinable, and other key management assumptions. Actual results may differ materially from those expressed or implied by such forwardlooking statements and involve risk and uncertainties relating to the Company’s historical experience with regulatory changes, timeliness of government approvals for the granting of permits and licenses, changes in marijuana prices, actual operating performance of facilities , and other uninsured risks. The Company assumes no responsibility to update or revise forward-looking information to reflect new events or circumstances unless required by law. Contents are provided for general information purposes only and do not constitute an offer to sell or solicitation of an offer to buy any security in any jurisdiction

2 Confidential & Proprietary

slide-3
SLIDE 3

Confidential & Proprietary

March 2019 TSX Up-listing TSX: ALEF

10 Million

Point Medical Cannabis Dataset

TSX Venture Top Performing Company of the Year

International Expansion

Canada | Australia

$570

Million Market Capitalization

138,000 kg

Planned, Funded Capacity

3

Production & Cultivation Facilities

3

60,000 Medical Patients

slide-4
SLIDE 4

SCIENCE

Data analytics and science-based medicine inform every decision, from strains to treatment. If it matters, measure it.

SEEDING

We seed change by disrupting established industries. Cross- platform integration and cannabis innovation is how we do it.

WELLNESS

Specialized treatment programs, tailored cannabis education courses, and product innovation. We deliver wellness through diversification.

Confidential & Proprietary

4

We Grow Together

With continuous innovation, research & development; we are creating the industry’s most reliable cannabis health & wellness consumer experience

slide-5
SLIDE 5

Confidential & Proprietary

5

4 divisions 1 journey

Continuous innovation, powered by technology to scale globally.

Our Ecosystem

We Grow Together

5 We drive continuous innovation in cannabis cultivation, processing, extraction and brand-building to deliver science-based cannabis health and wellness products for Aleafia Health consumers.

Cannabis Education & Certification Cannabis Consumer Experience

We leverage our global leading medical patient experience to create and share innovative courseware for MDs, nurses, patients, families and employers. Our responsibility is to lead and share our expertise in cannabis health and wellness. We educate, diagnose, treat and empower people to optimize health and wellness with cannabinoid therapy. From pain and anxiety, to paediatrics epilepsy and autism, we are there for our patients - in hospitals, clinics and in their homes via

  • nline telemedicine.

We are creating a unique, global, multi-jurisdictional compliant, ecommerce consumer

  • marketplace. It is a scalable,

cannabis sales platform that will complement our current national distribution network of provincial government and retail channels.

Health & Wellness Service Clinics Cannabis Product Innovation

slide-6
SLIDE 6

Confidential & Proprietary

6

Powered by Strong Relationship Ecosystem

4 Divisions

Aleafia Campus Health & Wellness Education Consumer Experience

ON OFF

Accelerating relationships allow us to achieve global scale while excelling in core competencies.

We Grow Together

slide-7
SLIDE 7

Confidential & Proprietary

7

We Grow Together

Securing Repeatable High-Margin Purchases Seeding Customer Loyalty Integrating the Consumer Journey

7

Cannabis Product & Consumer Journey

Cannabis Product Journey Cannabis Consumer Journey

Extraction Processing Grow & Quality Control Cultivation Distribution Canada > Global Learning & Sharing Doctor / Patient Engagement Education Cannabis Products & Brands Marketplace Purchase Product & Brands Information & Awareness Research

Our Ecosystem

slide-8
SLIDE 8

Confidential & Proprietary

8

Port Perry, ON

7,000 sq. ft.

Indoor hydroponic cultivation facility Port Perry, ON

26-Acre

Prime agricultural farmland dedicated to outdoor cultivation

$0.25 cost per gram target

Local approval secured, being re-zoned allowing industrial use. Pending Health Canada approval. Niagara, ON | Greenhouse

160,000 sq. ft.

Modern, automated moving container bench system to produce repeatable, standardized cannabis strains Product Innovation Centre

25,000 sq. ft.

Currently extracting oils, tinctures, sprays, gel caps

30,000 sq. ft. Phase II Expansion nearing completion

Formulation and analytical laboratory built to GMP certifications Low-Cost Supply

38,000 kg annual low-cost supply

Including largest ever LP-to-LP supply agreement Paris, ON

83-Acres

Prime agricultural land – zoned for industrial use. Internal best-use study currently underway. Paris, ON

2,000kg

Multi-format production capacity within Product Innovation Centre

Continuous innovation, powered by in-house medical and product expertise

Port Perry (Indoor): Cultivation & Wholesale Licenses Niagara (Greenhouse): Cultivation Licence (expected early Q2/19) Port Perry (Outdoor): Local Approval, Cultivation License (expected early Q2/19) Paris (Product Innovation): Cultivation, Medical & Non-medical Sales, and Processing Licences

slide-9
SLIDE 9

Confidential & Proprietary

9

9

Premium Non-Medical Premium Medical

Wholesale Value Mid-Point

Cannabis Health & Wellness Capturing High Margins Within Industry Growth Segments

$14.52

Aleafia Health average oil per gram selling price: “One of the highest amongst peers.”

  • Leading bank analyst

VS.

$8.02

Average price per gram sold in Canada

  • Statistics Canada

Industry leading price per gram sold with premium products and strong health & wellness consumer brand awareness.

Legal Cannabis Market Growth Premium Pricing With Brand Awareness & Product Innovation

2025

$146 Billion Total

Today

Medical

$100 Billion

Non-Medical

Confidential & Proprietary

slide-10
SLIDE 10

Confidential & Proprietary

10

Continuous product

  • Innovation. Powered by

research, experience, consumer brand awareness and loyalty.

Established Cannabis Brands Proven Cannabis Consumer Products

Quality Grown Cannabis Strains

THC – CBD – Hybrids Sativa – Indica - Hybrids

Market Leading Format Breadth

Flower, Oil, Capsules, Sprays

High Quality Premium Medical Cannabis Products Focused on High Margins Commercially Proven Non-Medical Cannabis Products (Adult-Use / Recreational) Future CPG Brand Integrations Focused on Health & Wellness Lifestyle Products

slide-11
SLIDE 11

Confidential & Proprietary

Retailers

Canada Medical Canada Non-Medical

Adult-Use / Recreational National, Global Distribution Platform

Global Export

  • Canada’s largest clinic network
  • 900+ Canadian MDs and

Nurse Practitioners

  • 60,000+ Patients

Highly coveted supply agreement with Shoppers Drug Mart Australia

Launching in Q21

Provincial Distribution Health & Wellness Services Listing with Canada’s largest pharmacy Global Expansion

11

  • 1. Pending regulatory approval.
slide-12
SLIDE 12

Confidential & Proprietary

Built for Businesses, Corporations, Colleges / Universities, Governments, Associations, Regulatory Bodies, Unions, Insurance, Benefits

Joint medical cannabis study to improve the management and treatment of insomnia and daytime sleepiness. Cannabinoid pharmacogenetics in medical cannabis therapy study with G420 and AKESOgen. Study in progress. Of patients who stopped using benzodiazepines following medical cannabis treatment. Published in Journal of Cannabis & Cannabinoid Research.

45%

Epileptic patients improved employment status in first of its kind, 4000 patient study To be published in Journal of Drug Issues.

We Grow Together

12

10 million

point medical cannabis dataset

Continuous research powered by technology to seed wellness

...driving new cannabis products and services

Treatment Innovation

slide-13
SLIDE 13

Confidential & Proprietary

Health & Wellness Services / Clinics

Patient on-boarding, diagnosing and treatments tuned

  • ver 4+ years across hundreds of thousands of patient

encounters.

Global Medical Cannabinoid Therapy Expertise

Diagnosis, treatment and scripting by Physicians, Nurse Practitioners in-clinic and by video conference / Tele-Medicine at home. All patient data monitored and collected, from scripting, diagnosis, to purchasing.

Experienced Patient Journeys

60,000+

Patients Seen to Date

Canada’s Largest Medical Cannabis Clinical Network

  • Dr. Michael Verbora

Chief Medical Officer

  • Over 4000 cannabinoid therapy

consultations

Focus Areas For Cannabinoid Therapy Pain Cancer Anxiety Palliative Care Gastrointestinal Diseases Neurological Disorders Paediatrics Epilepsy Paediatrics Autism

13

10 Million

Point Medical Cannabis Dataset

We Grow Together

slide-14
SLIDE 14

Confidential & Proprietary

Courses

  • Cannabis 101, Cannabis in

the Workplace

  • For Doctors, Nurses,

Healthcare Professionals

  • Patients & Family

Members

+ Certifications & Licensing

Software-as-a-Service Learning Management System (LMS)

Animation Video Narration Interactivity Gamification Social Sharing Student Management

Built for Corporations, Colleges & Universities, Governments, Associations, Regulatory Bodies, Unions, Insurance Providers Cannabis Education & Certifications

Powered by Experience

Patients, Engagements, Case Studies Proprietary Research

Global Edge

with 4+ years,

60,000 patients

We Grow Together

14

Continuous research and patient engagement powered by science seeding learning COMING SOON

In partnership with

slide-15
SLIDE 15

Global Scale

Confidential & Proprietary

Continuous consumer marketplace innovation, powered by technology to scale globally Global data warehouse supporting all 4 divisions with leading cannabis reporting, analytics, business insights, and AI Gamification, reward & loyalty platform Subscription and Home Delivery Support Consumer brand ambassadors supporting phone, chat, email and social consumer engagements

Online Marketplace

Medical and Non-Medical1

(Adult-Use / Recreational)

Proprietary scaling eCommerce Platform

Consumer Journey of Purchasing Medical Cannabis Products Online

The Health & Wellness Cannabis Consumer Experience & Lifestyle

We Grow Together

15

Health & Wellness Cannabis Lifestyle & Experience

We are where our consumers are

Continuous personalization, powered by technology to deliver exceptional consumer experiences.

Our Marketplace

COMING SOON

  • 1. When and where permitted by federal and local law.

Multi-jurisdiction compliance, multi-language and multi-currency

slide-16
SLIDE 16

Confidential & Proprietary

16

Geoff Benic

Chief Executive Officer

Benjamin Ferdinand

Chief Financial Officer

Trevor Newell

Chief Marketing & Technology Officer

Greg Rossi

Chief Operating Officer

  • Dr. Michael Verbora

Chief Medical Officer

Keith White

President of Clinics

Lucas Escott

SVP Production

“By seeking a new form of care, our patients have the courage to do things

  • differently. They are our inspiration, and that differentiation our mantra.”

Management

slide-17
SLIDE 17

17

William Stewart Lea Ray Daniel Milliard Raf Souccar Loreto Grimaldi Mark Sandler

Board

Julian Fantino

Chairman

“Trust and accountability are paramount. To our team, to our shareholders, and to our patients.”

slide-18
SLIDE 18

Confidential & Proprietary

18

$600~ Million Market Capitalization1 3 Cultivation & Production Facilities 138,000 kg Funded, Planned Cultivation Capacity 43.6% Q/Q Revenue Growth2 78 Product SKUs 163 Acres of Land Owned

Confidential & Proprietary

Investment Highlights

1. Pro-Forma at Market close, 13/3/19 2. Aleafia Health, Emblem pro-forma Q3/18 v. Q2/18

18

slide-19
SLIDE 19

Confidential & Proprietary

60,000+

Patients Seen to Date

Canada’s Largest Medical Cannabis Clinical Network

26-Acre

prime agricultural farmland for ultra low-cost outdoor cultivation

160,000 sq. ft.

Automated Niagara Greenhouse

Nicholas Bergamini

VP Investor Relations & Communications

IR@AleafiaHealth.com AleafiaHealth.com

19

10 Million Point Medical Cannabis Dataset Proprietary, globally scaling eCommerce Platform